COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 429
[11] Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF,
Gale EA. Prediction of IDDM in the general population: strategies
based on combinations of autoantibody markers. Diabetes.
1997;46(11):1701-1710.
[12] Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific
autoantibodies precede the symptoms of rheumatoid arthritis: a
study of serial measurements in blood donors. Arthritis Rheum.
2004;50(2):380-386.
[13] Kuhle J, Pohl C, Mehling M, et al. Lack of association between
antimyelin antibodies and progression to multiple sclerosis. N Engl J
Med. 2007;356(4):371-378.
[14] Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A,
Mantilla RD, Anaya JM. Introducing polyautoimmunity: secondary
autoimmune diseases no longer exist. Autoimmune Dis.
2012;2012:254319.
[15] Somers EC, Thomas SL, Smeeth L, Hall AJ. Autoimmune
diseases co-occurring within individuals and within families: a
systematic review. Epidemiology. 2006;17(2):202-217.
[16] Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME. Definition
of human autoimmunity--autoantibodies versus autoimmune
disease. Autoimmun Rev. 2010;9(5):A259-A266.
[17] Bizzaro N, Antico A, Platzgummer S. Autoantibody profiling
and early diagnosis of autoimmune diseases. Autoimmun Rev.
2020;19(5):102491.
[18] Cooper GS, Stroehla BC. The epidemiology of autoimmune
diseases. Autoimmun Rev. 2003;2(3):119-125.
[19] Shoenfeld Y, et al. The mosaic of autoimmunity: prediction,
autoantibodies, and therapy in autoimmune diseases. Isr Med
Assoc J. 2008;10(1):13-19.
429
